BLACKROCK SCI & TECH TRM TR (BSTZ) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:BSTZ - US09260K1016
22.1 USD
+0.3 (+1.38%)
Overall BSTZ gets a fundamental rating of 2 out of 10. We evaluated BSTZ against 0 industry peers in the Unkown industry. BSTZ may be in some trouble as it scores bad on both profitability and health. BSTZ is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year BSTZ was profitable.
BSTZ had a positive operating cash flow in the past year.
Of the past 5 years BSTZ 4 years were profitable.
BSTZ had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.03% | ||
| ROE | 9.39% | ||
| ROIC | 11.26% |
ROA(3y)-17.73%
ROA(5y)0.59%
ROE(3y)-17.95%
ROE(5y)0.68%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of BSTZ has grown nicely.
In the last couple of years the Operating Margin of BSTZ has declined.
BSTZ's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 91.06% | ||
| PM (TTM) | 58.54% | ||
| GM | 91.69% |
OM growth 3Y0.3%
OM growth 5Y-8.94%
PM growth 3Y20.98%
PM growth 5YN/A
GM growth 3Y0.51%
GM growth 5Y-8.53%
2. Health
2.1 Basic Checks
BSTZ has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, BSTZ has less shares outstanding
Compared to 1 year ago, BSTZ has a worse debt to assets ratio.
2.2 Solvency
BSTZ has an Altman-Z score of 15.61. This indicates that BSTZ is financially healthy and has little risk of bankruptcy at the moment.
The Debt to FCF ratio of BSTZ is 0.08, which is an excellent value as it means it would take BSTZ, only 0.08 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.02 indicates that BSTZ is not too dependend on debt financing.
Although BSTZ does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.08 | ||
| Altman-Z | 15.61 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
A Current Ratio of 0.26 indicates that BSTZ may have some problems paying its short term obligations.
A Quick Ratio of 0.26 indicates that BSTZ may have some problems paying its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.26 | ||
| Quick Ratio | 0.26 |
3. Growth
3.1 Past
The earnings per share for BSTZ have decreased strongly by -25.36% in the last year.
BSTZ shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.63% yearly.
Looking at the last year, BSTZ shows a very strong growth in Revenue. The Revenue has grown by 148.16%.
BSTZ shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.19% yearly.
EPS 1Y (TTM)-25.36%
EPS 3Y6.9%
EPS 5Y21.63%
EPS Q2Q%-81.13%
Revenue 1Y (TTM)148.16%
Revenue growth 3Y-14.19%
Revenue growth 5YN/A
Sales Q2Q%57.69%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.57 indicates a reasonable valuation of BSTZ.
Compared to an average S&P500 Price/Earnings ratio of 26.31, BSTZ is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.57 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.42 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.49
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 11.98%, BSTZ is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.40, BSTZ pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.98% |
5.2 History
BSTZ has been paying a dividend for over 5 years, so it has already some track record.
BSTZ has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
BSTZ pays out 132.64% of its income as dividend. This is not a sustainable payout ratio.
DP132.64%
EPS Next 2YN/A
EPS Next 3YN/A
NYSE:BSTZ (11/28/2025, 5:04:00 PM)
22.1
+0.3 (+1.38%)
Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)
Earnings (Next)
Inst Owners27.77%
Inst Owner Change-7.93%
Ins Owners0.17%
Ins Owner Change0%
Market Cap1.52B
Revenue(TTM)246.00M
Net Income(TTM)144.00M
Analysts0
Price TargetN/A
Short Float %0.14%
Short Ratio0.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.98% |
Yearly Dividend2.05
Dividend Growth(5Y)N/A
DP132.64%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.57 | ||
| Fwd PE | N/A | ||
| P/S | 6.18 | ||
| P/FCF | 4.42 | ||
| P/OCF | 4.42 | ||
| P/B | 0.99 | ||
| P/tB | 0.99 | ||
| EV/EBITDA | N/A |
EPS(TTM)2.09
EY9.46%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)5
FCFY22.64%
OCF(TTM)5
OCFY22.64%
SpS3.58
BVpS22.3
TBVpS22.3
PEG (NY)N/A
PEG (5Y)0.49
Graham Number32.38
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.03% | ||
| ROE | 9.39% | ||
| ROCE | 14.25% | ||
| ROIC | 11.26% | ||
| ROICexc | 11.26% | ||
| ROICexgc | 11.26% | ||
| OM | 91.06% | ||
| PM (TTM) | 58.54% | ||
| GM | 91.69% | ||
| FCFM | 139.84% |
ROA(3y)-17.73%
ROA(5y)0.59%
ROE(3y)-17.95%
ROE(5y)0.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y4.88%
ROICexgc growth 5YN/A
ROICexc growth 3Y4.97%
ROICexc growth 5YN/A
OM growth 3Y0.3%
OM growth 5Y-8.94%
PM growth 3Y20.98%
PM growth 5YN/A
GM growth 3Y0.51%
GM growth 5Y-8.53%
F-Score6
Asset Turnover0.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.08 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 22400 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 238.89% | ||
| Current Ratio | 0.26 | ||
| Quick Ratio | 0.26 | ||
| Altman-Z | 15.61 |
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25.36%
EPS 3Y6.9%
EPS 5Y21.63%
EPS Q2Q%-81.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)148.16%
Revenue growth 3Y-14.19%
Revenue growth 5YN/A
Sales Q2Q%57.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y194.75%
EBIT growth 3Y-13.93%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76.32%
FCF growth 3Y2.74%
FCF growth 5YN/A
OCF growth 1Y76.32%
OCF growth 3Y2.74%
OCF growth 5YN/A
BLACKROCK SCI & TECH TRM TR / BSTZ FAQ
What does BLACKROCK SCI & TECH TRM TR do?
BlackRock Science and Technology Term Trust is a US-based company operating in industry. The company is headquartered in Wilmington, Delaware. The company went IPO on 2019-06-26. BlackRock Science and Technology Term Trust (the Trust) is a closed-end management investment company. The Trust's investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities issued by the United States and non-United States science and technology companies in any market capitalization range, selected for their rapid and sustainable growth potential from the development, advancement and use of science and/or technology. The Trust focuses on sectors, such as semiconductors and semiconductor equipment, software, electronic equipment, instruments and components, entertainment, financial services, automobiles, professional services, diversified consumer services, media and others. BlackRock Advisors, LLC is the Trust’s investment adviser.
Can you provide the latest stock price for BLACKROCK SCI & TECH TRM TR?
The current stock price of BSTZ is 22.1 USD. The price increased by 1.38% in the last trading session.
What is the ChartMill technical and fundamental rating of BSTZ stock?
BSTZ has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.